Walbert Timothy P's Form 4 filing
Horizon Therapeutics Public Ltd Co (HZNP) · filed Jun 2, 2022
- Accession no.
- 0001209191-22-033505
- Filed
- Jun 2, 2022
- Trade date
- May 31, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.31M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Walbert Timothy PCIK 0001349376 | Director, Officer (Chairman, President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 31, 2022 | Ordinary Shares | SSaleDisposed | −18,500 | $92.04 | −$1,702,740 | 442,049 | Direct | |
| May 31, 2022 | Ordinary Shares | SSaleDisposed | −3,800 | $93.21 | −$354,198 | 438,249 | Direct | |
| May 31, 2022 | Ordinary Shares | SSaleDisposed | −2,700 | $94.46 | −$255,042 | 435,549 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.